Valuation: Labcorp Holdings Inc.

Market Cap 23.24B 20.31B 18.74B 17.27B 32.55B 2,238B 33.28B 224B 88.09B 1,096B 87.26B 85.35B 3,773B P/E 2026 *
19.5x
P/E 2027 * 18.4x
Enterprise Value 27.87B 24.35B 22.47B 20.72B 39.04B 2,684B 39.91B 269B 106B 1,314B 105B 102B 4,525B EV / Sales 2026 *
1.89x
EV / Sales 2027 * 1.76x
Free-Float
99.65%
Yield 2026 *
1.03%
Yield 2027 * 1.04%
1 day+0.50%
1 week+2.37%
Current month+1.20%
1 month+10.77%
3 months+4.68%
6 months+4.61%
Current year+12.95%
1 week 262.1
Extreme 262.105
290.65
1 month 253.05
Extreme 253.05
291.38
Current year 245
Extreme 245
292.02
1 year 241.81
Extreme 241.81
293.72
3 years 191.97
Extreme 191.97
293.72
5 years 191.97
Extreme 191.97
317.17
10 years 98.02
Extreme 98.02
317.17
Date Insider Type Main position Quantity % Market Cap.
02/07/26 Sell

EVP and President, Diagnostics

-234 0.0003%
02/07/26 Sell

General Counsel

-92 0.0001%
08/06/26 Sell

General Counsel

-762 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%+2.37%+16.26%+33.21% 23.24B
+0.58%+0.53%+95.39%+457.61% 38.87B
+0.64%+3.01%-20.75%-38.52% 7.55B
-1.27%-5.20%+8.18%+82.59% 4.89B
-2.61%-0.32%+12.36%+42.73% 2.93B
-1.55%+3.54%+134.13%-14.91% 1.9B
+2.90%-3.29%-18.48%+756.68% 1.88B
-5.48%+7.11%-10.82%-62.13% 1.8B
+7.73%+1.04%+31.35%+8.15% 1.76B
-13.79%-10.75%+15.06%-19.49% 1.65B
Average -1.23%-0.59%+26.27%+124.59% 8.65B
Weighted average by Cap. +0.10%+0.72%+49.56%+232.04%

Financials

2026 *2027 *
Net sales 14.71B 12.86B 11.86B 10.94B 20.61B 1,417B 21.07B 142B 55.77B 694B 55.25B 54.04B 2,389B 15.42B 13.47B 12.43B 11.46B 21.6B 1,485B 22.08B 149B 58.45B 727B 57.9B 56.63B 2,503B
Net income 1.18B 1.04B 955M 881M 1.66B 114B 1.7B 11.42B 4.49B 55.88B 4.45B 4.35B 192B 1.23B 1.07B 992M 914M 1.72B 118B 1.76B 11.86B 4.66B 58.02B 4.62B 4.52B 200B
Net Debt 4.63B 4.05B 3.74B 3.44B 6.49B 446B 6.64B 44.66B 17.56B 219B 17.4B 17.02B 752B 3.95B 3.45B 3.18B 2.93B 5.53B 380B 5.65B 38.03B 14.96B 186B 14.82B 14.49B 641B
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Employees
66,385
Date Price Change Volume
17/07/26 $283.36 +0.50% 631,872
16/07/26 $281.94 +3.66% 554,817
15/07/26 $271.99 -1.34% 809,589
14/07/26 $275.68 -0.36% 751,715
13/07/26 $276.68 -0.05% 396,275
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
283.36USD
Average target price
312.35USD
Spread / Average Target
+10.23%

Quarterly revenue - Rate of surprise